Plasma p‐tau 217 may represent a non‐invasive biomarker, and it exhibited superior diagnostic performance over other plasma Aβ biomarkers for differentiating CAA from AD and CAA from DPA. The gene discussed is MAPT; the disease is Alzheimer disease.